The private sector dominates biotechnology research in industrialized countries, but there are major market failures in developing countries in accessing the new tools and technologies. The public sector, national and international, will have to play a major role in filling this gap. This paper provides an overview of options that countries of different sizes and capacities can employ to gain access to the research tools and technologies that they need to address issues of relevance to poor producers and consumers.
More and more, development organizations are under pressure to demonstrate that their programs result in significant and lasting changes in the well-being of their intended beneficiaries. However, such "impacts" are often the product of a confluence of events for which no single agency or group of agencies can realistically claim full credit. As a result, assessing development impacts is problematic, yet many organizations continue to struggle to measure results far beyond the reach of their programs
International partnership to carry out collaborative research and development programs has been implemented for a long time. However, with globalization, the economic, social, political and cultural diversity of interacting partners reached levels where this variety of collaborators often has shown some weaknesses in issues like governance. Strong and sound partnerships must be manageable in order to ensure the achievement of the set objectives.
Este documento tiene como propósito brindar recomendaciones para integrar el enfoque de género y equidad en las empresas rurales asociativas. Están basadas en la experiencia de MAP Noruega con la Escuela de Formación Empresarial (EFET), en la estrategia de género y equidad de MAP y en otras experiencias reportadas en la literatura sobre este mismo tema.